News for Healthier Living
Children's Hospital Los Angeles Studies New Gene-Editing Approach for Sickle Cell Disease
Children's Hospital Los Angeles is participating in RESTORE, an early-stage clinical trial studying an investigational CRISPR-Cas9 therapy designed to directly modify the beta-globin gene in sickle cell disease.
July 27, 2026
July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026
|
|
|
|
|